300760 Stock Overview Shenzhen Mindray Bio-Medical Electronics Co., Ltd. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Add noteShenzhen Mindray Bio-Medical Electronics Co., Ltd. Competitors Price History & Performance
Summary of share price highs, lows and changes for Shenzhen Mindray Bio-Medical Electronics Historical stock prices Current Share Price CN¥232.40 52 Week High CN¥351.60 52 Week Low CN¥221.66 Beta 0.23 1 Month Change -6.23% 3 Month Change -12.71% 1 Year Change -13.10% 3 Year Change -28.11% 5 Year Change 7.66% Change since IPO 123.94%
Recent News & Updates
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025 Dec 31
Third quarter 2024 earnings released: EPS: CN¥2.54 (vs CN¥2.80 in 3Q 2023) Oct 30
Investor sentiment deteriorates as stock falls 17% Oct 15
Now 24% undervalued after recent price drop Oct 15
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Sep 30
Investor sentiment improves as stock rises 16% Sep 27 See more updates
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025 Dec 31
Third quarter 2024 earnings released: EPS: CN¥2.54 (vs CN¥2.80 in 3Q 2023) Oct 30
Investor sentiment deteriorates as stock falls 17% Oct 15
Now 24% undervalued after recent price drop Oct 15
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Sep 30
Investor sentiment improves as stock rises 16% Sep 27
Second quarter 2024 earnings released: EPS: CN¥3.63 (vs CN¥3.19 in 2Q 2023) Aug 31
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Proposes Interim Dividend for the First Half of 2024 Aug 31
Now 21% undervalued May 31
Dividend of CN¥1.50 announced May 23
Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Annual General Meeting, May 17, 2024 Apr 29
Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Annual General Meeting, May 17, 2024 Apr 28
First quarter 2024 earnings released: EPS: CN¥2.61 (vs CN¥2.13 in 1Q 2023) Apr 27
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024 Mar 30
Now 20% undervalued after recent price drop Jan 29
Now 20% undervalued Jan 17
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024 Dec 30
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Implements Profit Distribution for Third Quarter of 2023, Payable on 22 November 2023 Nov 17
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Approves Profit Distribution Plan for Third Quarter 2023 Nov 15 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Proposes Third Quarterly Dividend Oct 31
Third quarter 2023 earnings released: EPS: CN¥2.80 (vs CN¥2.33 in 3Q 2022) Oct 29
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. to Report Q3, 2023 Results on Oct 30, 2023 Sep 30
Second quarter 2023 earnings released: EPS: CN¥3.19 (vs CN¥2.63 in 2Q 2022) Aug 30 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Approves Cash Dividend for 2022
Full year 2022 earnings released: EPS: CN¥7.94 (vs CN¥6.59 in FY 2021) Apr 28
Mindray Revolutionizes the Way of Using Ultrasound with TE Air, Its First Wireless Handheld Ultrasound System Feb 15
Mindray Introduces New Wearable Patient Monitoring System, Refining Clinician’s Workflow to Track Patient Conditions Dec 05
Less than half of directors are independent Nov 16
Third quarter 2022 earnings released: EPS: CN¥2.33 (vs CN¥1.91 in 3Q 2021) Oct 29
Investor sentiment improved over the past week Sep 30
Second quarter 2022 earnings released: EPS: CN¥2.63 (vs CN¥2.16 in 2Q 2021) Aug 21
Mindray Reimagines Point of Care Systems with Launch of New TEX20 Diagnostic Ultrasound Series At Euroanaesthesia 2022 Jun 15 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 19 May 2022
Less than half of directors are independent Apr 27
Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Annual General Meeting, May 10, 2022 Apr 22
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Proposes Final Dividend for the Year 2021 Apr 21
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760) announces an Equity Buyback for CNY 1,000 million worth of its shares. Jan 14
Third quarter 2021 earnings released: EPS CN¥1.91 (vs CN¥1.57 in 3Q 2020) Oct 20
Mindray Launches New MC-80 Automated Digital Cell Morphology Analyzer, Taking Morphology Analysis to the Next Level Sep 29
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760) completed the acquisition of HyTest Ltd. from Summa Equity. Sep 24
Mindray Announces the Launch of its Latest Point-Of-Care (POC) Ultrasound System, the TE9 Sep 11
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760) announces an Equity Buyback for CNY 1,000 million worth of its shares. Aug 27
Second quarter 2021 earnings released: EPS CN¥2.16 (vs CN¥1.76 in 2Q 2020) Aug 27
Investor sentiment deteriorated over the past week Aug 21
Mindray Unveils Nuewa I9, A New Ob/GYN Diagnostic Ultrasound System Jun 09
Mindray Launches Resona I9 Ultrasound System, Revolutionizing General Imaging Jun 03
Mindray Defines Future of Imaging Technologies with New General Imaging, Women's Healthcare and Cardiology Ultrasound Solutions May 31
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Approves Cash Dividend for the Year 2020, Payable on 28 May 2021 May 22
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Proposes Final Dividend for the Year 2020 Apr 30
First quarter 2021 earnings released: EPS CN¥1.41 (vs CN¥1.08 in 1Q 2020) Apr 30
New 90-day low: CN¥348 Mar 10
New 90-day high: CN¥492 Feb 09
Mindray Launches New BeneFusion e Series Infusion Systems, Delivering Efficiency in Every Droplet Feb 03
Mindray Transforms Spot Check Patient Monitoring with New VS Series Vital Signs Monitors Jan 28
New 90-day high: CN¥478 Jan 22
New 90-day high: CN¥418 Dec 30
New 90-day high: CN¥405 Nov 04
Third quarter earnings released Oct 30
Mindray Brings New Systems to the High-End Anesthesia System Market Oct 16
New 90-day high: CN¥358 Oct 10
First half earnings released Aug 29
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020 Aug 13 Shareholder Returns 300760 CN Medical Equipment CN Market 7D -0.7% -0.3% -0.9% 1Y -13.1% -0.6% 22.0%
See full shareholder returns
Return vs Market: 300760 underperformed the CN Market which returned 22% over the past year.
Price Volatility Is 300760's price volatile compared to industry and market? 300760 volatility 300760 Average Weekly Movement 3.7% Medical Equipment Industry Average Movement 5.4% Market Average Movement 6.7% 10% most volatile stocks in CN Market 10.7% 10% least volatile stocks in CN Market 3.9%
Stable Share Price: 300760 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300760's weekly volatility (4%) has been stable over the past year.
About the Company Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions worldwide. The company offers patient monitoring and life support products, such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, endoscopes, and accessories, as well as emergency care, peri-operative care, critical care, and IT solutions.
Show more Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Fundamentals Summary How do Shenzhen Mindray Bio-Medical Electronics's earnings and revenue compare to its market cap? 300760 fundamental statistics Market cap CN¥281.06b Earnings (TTM ) CN¥12.38b Revenue (TTM ) CN¥37.11b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 300760 income statement (TTM ) Revenue CN¥37.11b Cost of Revenue CN¥12.65b Gross Profit CN¥24.47b Other Expenses CN¥12.08b Earnings CN¥12.38b
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 29, 2025
Earnings per share (EPS) 10.24 Gross Margin 65.92% Net Profit Margin 33.37% Debt/Equity Ratio 0.3%
How did 300760 perform over the long term?
See historical performance and comparison Dividends
3.1% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/01 20:55 End of Day Share Price 2025/01/27 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is covered by 52 analysts. 30 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Sandra Sun BofA Global Research Zhishun Siu CCB International Securities Limited Yue Gao Changjiang Securities Co. LTD.
Show 49 more analysts